Agree HoundZ11, objective points well made.
Your gist is correct, Biotech is about development of product and just as importantly effective commercialisation of that developed product. The appointment of SC, TL and the new CFO by ND is about that effective commercialisation which will in turn lead to a share price that reflects that effectiveness. So if they get that right the options will look after themselves.
As far as TB on the board, that's the last place we want her, let her focus on what she does best, the science and its development!
Agree HoundZ11, objective points well made. Your gist is...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable